Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

BACKGROUND: Although accumulated evidence provides a strong scientific premise for using immune profiles to predict survival in patients with cancer, a universal immune profile across tumor types is still lacking, and how to achieve a survival-associated immune profile remains to be evaluated. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qingnan, Hu, Jiemiao, Mitra, Abhisek, Cutrera, Jeffry, Zhang, Wendong, Zhang, Zhongting, Yan, Jun, Xia, Xueqing, Mahadeo, Kris Michael, Livingston, John Andrew, Gorlick, Richard, Li, Shulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580640/
https://www.ncbi.nlm.nih.gov/pubmed/31208461
http://dx.doi.org/10.1186/s40425-019-0631-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580640/
https://www.ncbi.nlm.nih.gov/pubmed/31208461
http://dx.doi.org/10.1186/s40425-019-0631-z

Ejemplares similares